Coya Therapeutics (COYA) EPS (Diluted) Growth (1y) (2023 - 2026)
Coya Therapeutics (COYA) EPS (Diluted) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Coya Therapeutics | 97.60 Mn | 46.87 Mn | - | 27.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.17% |
| Dec 31, 2025 | 36.08% |
| Sep 30, 2025 | 47.13% |
| Jun 30, 2025 | -87.97% |
| Mar 31, 2025 | -25.06% |
| Dec 31, 2024 | -113.74% |
| Sep 30, 2024 | -20.66% |
| Jun 30, 2024 | 56.55% |
| Mar 31, 2024 | 14.66% |
| Dec 31, 2023 | 67.67% |
| Sep 30, 2023 | 55.68% |
| Jun 30, 2023 | 66.46% |
| Mar 31, 2023 | 37.63% |